GlucoTrack Statistics
Total Valuation
GlucoTrack has a market cap or net worth of $6.03 million. The enterprise value is -$3.45 million.
Important Dates
The next estimated earnings date is Thursday, November 13, 2025, after market close.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
GlucoTrack has 899,410 shares outstanding.
| Current Share Class | 899,410 |
| Shares Outstanding | 899,410 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +192.01% |
| Owned by Insiders (%) | 1.24% |
| Owned by Institutions (%) | 1.54% |
| Float | 842,486 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.85 |
| P/TBV Ratio | 0.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.27, with a Debt / Equity ratio of 0.04.
| Current Ratio | 3.27 |
| Quick Ratio | 3.10 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -24.52 |
Financial Efficiency
Return on equity (ROE) is -1,490.95% and return on invested capital (ROIC) is -465.85%.
| Return on Equity (ROE) | -1,490.95% |
| Return on Assets (ROA) | -177.93% |
| Return on Invested Capital (ROIC) | -465.85% |
| Return on Capital Employed (ROCE) | -216.13% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.43M |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.73% in the last 52 weeks. The beta is 0.22, so GlucoTrack's price volatility has been lower than the market average.
| Beta (5Y) | 0.22 |
| 52-Week Price Change | -99.73% |
| 50-Day Moving Average | 6.26 |
| 200-Day Moving Average | 19.89 |
| Relative Strength Index (RSI) | 49.48 |
| Average Volume (20 Days) | 107,318 |
Short Selling Information
The latest short interest is 84,028, so 9.34% of the outstanding shares have been sold short.
| Short Interest | 84,028 |
| Short Previous Month | 391,903 |
| Short % of Shares Out | 9.34% |
| Short % of Float | 9.97% |
| Short Ratio (days to cover) | 0.02 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -15.40M |
| Pretax Income | -26.77M |
| Net Income | -26.77M |
| EBITDA | -15.36M |
| EBIT | -15.40M |
| Earnings Per Share (EPS) | -$157.67 |
Full Income StatementBalance Sheet
The company has $9.56 million in cash and $267,000 in debt, giving a net cash position of $9.29 million or $10.33 per share.
| Cash & Cash Equivalents | 9.56M |
| Total Debt | 267,000 |
| Net Cash | 9.29M |
| Net Cash Per Share | $10.33 |
| Equity (Book Value) | 6.88M |
| Book Value Per Share | 7.65 |
| Working Capital | 6.99M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$14.32 million and capital expenditures -$42,000, giving a free cash flow of -$14.37 million.
| Operating Cash Flow | -14.32M |
| Capital Expenditures | -42,000 |
| Free Cash Flow | -14.37M |
| FCF Per Share | -$15.97 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
